Citigroup’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $160K | Sell |
128,918
-153,323
| -54% | -$190K | ﹤0.01% | 3443 |
|
|
2025
Q1 | $333K | Buy |
282,241
+44,550
| +19% | +$52.6K | ﹤0.01% | 3147 |
|
|
2024
Q4 | $435K | Buy |
237,691
+8,591
| +4% | +$15.7K | ﹤0.01% | 3117 |
|
|
2024
Q3 | $389K | Buy |
229,100
+111,697
| +95% | +$190K | ﹤0.01% | 3143 |
|
|
2024
Q2 | $161K | Buy |
117,403
+66,397
| +130% | +$91K | ﹤0.01% | 3276 |
|
|
2024
Q1 | $191K | Sell |
51,006
-5,307
| -9% | -$19.9K | ﹤0.01% | 3312 |
|
|
2023
Q4 | $552K | Sell |
56,313
-65,552
| -54% | -$643K | ﹤0.01% | 2621 |
|
|
2023
Q3 | $1.02M | Sell |
121,865
-14,480
| -11% | -$121K | ﹤0.01% | 1894 |
|
|
2023
Q2 | $1.81M | Buy |
136,345
+118,613
| +669% | +$1.58M | ﹤0.01% | 1771 |
|
|
2023
Q1 | $205K | Sell |
17,732
-1,837
| -9% | -$21.3K | ﹤0.01% | 3103 |
|
|
2022
Q4 | $160K | Sell |
19,569
-7,186
| -27% | -$58.8K | ﹤0.01% | 3150 |
|
|
2022
Q3 | $155K | Sell |
26,755
-18,154
| -40% | -$105K | ﹤0.01% | 3185 |
|
|
2022
Q2 | $198K | Buy |
44,909
+2,628
| +6% | +$11.6K | ﹤0.01% | 3203 |
|
|
2022
Q1 | $384K | Sell |
42,281
-44,885
| -51% | -$408K | ﹤0.01% | 3015 |
|
|
2021
Q4 | $1.78M | Buy |
87,166
+25,455
| +41% | +$521K | ﹤0.01% | 2065 |
|
|
2021
Q3 | $1.58M | Buy |
61,711
+10,906
| +21% | +$279K | ﹤0.01% | 2071 |
|
|
2021
Q2 | $1.78M | Buy |
50,805
+21,095
| +71% | +$738K | ﹤0.01% | 2172 |
|
|
2021
Q1 | $990K | Sell |
29,710
-36,668
| -55% | -$1.22M | ﹤0.01% | 2390 |
|
|
2020
Q4 | $1.72M | Buy |
66,378
+45,071
| +212% | +$1.17M | ﹤0.01% | 1803 |
|
|
2020
Q3 | $210K | Sell |
21,307
-33,010
| -61% | -$325K | ﹤0.01% | 2756 |
|
|
2020
Q2 | $187K | Buy |
54,317
+2,378
| +5% | +$8.19K | ﹤0.01% | 3113 |
|
|
2020
Q1 | $159K | Buy |
51,939
+9,044
| +21% | +$27.7K | ﹤0.01% | 2993 |
|
|
2019
Q4 | $220K | Sell |
42,895
-131,165
| -75% | -$673K | ﹤0.01% | 3091 |
|
|
2019
Q3 | $898K | Sell |
174,060
-83,532
| -32% | -$431K | ﹤0.01% | 2193 |
|
|
2019
Q2 | $1.56M | Sell |
257,592
-1,990,931
| -89% | -$12M | ﹤0.01% | 1819 |
|
|
2019
Q1 | $16.3M | Buy |
2,248,523
+632,464
| +39% | +$4.57M | 0.02% | 539 |
|
|
2018
Q4 | $12M | Buy |
1,616,059
+1,586,116
| +5,297% | +$11.7M | 0.01% | 626 |
|
|
2018
Q3 | $162K | Buy |
29,943
+16,282
| +119% | +$88.1K | ﹤0.01% | 3282 |
|
|
2018
Q2 | $48K | Buy |
13,661
+12,703
| +1,326% | +$44.6K | ﹤0.01% | 3898 |
|
|
2018
Q1 | $2K | Sell |
958
-3,132
| -77% | -$6.54K | ﹤0.01% | 4757 |
|
|
2017
Q4 | $11K | Sell |
4,090
-3,673
| -47% | -$9.88K | ﹤0.01% | 4461 |
|
|
2017
Q3 | $41K | Sell |
7,763
-516
| -6% | -$2.73K | ﹤0.01% | 3739 |
|
|
2017
Q2 | $29K | Sell |
8,279
-2,538
| -23% | -$8.89K | ﹤0.01% | 3811 |
|
|
2017
Q1 | $56K | Sell |
10,817
-46,933
| -81% | -$243K | ﹤0.01% | 3616 |
|
|
2016
Q4 | $219K | Buy |
57,750
+28,040
| +94% | +$106K | ﹤0.01% | 3517 |
|
|
2016
Q3 | $266K | Buy |
29,710
+3,690
| +14% | +$33K | ﹤0.01% | 2825 |
|
|
2016
Q2 | $184K | Sell |
26,020
-41,697
| -62% | -$295K | ﹤0.01% | 2926 |
|
|
2016
Q1 | $575K | Buy |
67,717
+39,561
| +141% | +$336K | ﹤0.01% | 2571 |
|
|
2015
Q4 | $369K | Buy |
28,156
+20,567
| +271% | +$270K | ﹤0.01% | 2599 |
|
|
2015
Q3 | $28K | Sell |
7,589
-7,243
| -49% | -$26.7K | ﹤0.01% | 3859 |
|
|
2015
Q2 | $86K | Sell |
14,832
-7,647
| -34% | -$44.3K | ﹤0.01% | 3362 |
|
|
2015
Q1 | $131K | Sell |
22,479
-4,348
| -16% | -$25.3K | ﹤0.01% | 3225 |
|
|
2014
Q4 | $210K | Buy |
26,827
+24,304
| +963% | +$190K | ﹤0.01% | 3123 |
|
|
2014
Q3 | $13K | Sell |
2,523
-2,955
| -54% | -$15.2K | ﹤0.01% | 4493 |
|
|
2014
Q2 | $33K | Sell |
5,478
-7,733
| -59% | -$46.6K | ﹤0.01% | 3844 |
|
|
2014
Q1 | $71K | Sell |
13,211
-10,276
| -44% | -$55.2K | ﹤0.01% | 3750 |
|
|
2013
Q4 | $123K | Buy |
23,487
+1,980
| +9% | +$10.4K | ﹤0.01% | 3545 |
|
|
2013
Q3 | $119K | Buy |
21,507
+1,640
| +8% | +$9.07K | ﹤0.01% | 3003 |
|
|
2013
Q2 | $50K | Buy |
+19,867
| New | +$50K | ﹤0.01% | 3771 |
|